Canadian medical cannabis company Tetra Bio-Pharma Inc. has permanently named Guy Chamberland as CEO and chief scientific officer after he assumed the role on an interim basis in April.

Chamberland has been the chief scientific officer and regulatory affairs of Tetra since June 2016.

Orleans, Ontario-based Tetra Bio-Pharma is a development stage medicinal cannabis company, which focuses on developing biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements.